Actual Medicinal Product (AMP) - Ibrance 125mg tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Ibrance 125mg tablets | Start Date 18-01-2021 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| Code | Start Date | End Date |
|---|---|---|
| 39274011000001100 | 18-01-2021 |
Parent Products
-
VTMPalbociclib
-
VMPPalbociclib 125mg tablets
-
AMP(Current) Ibrance 125mg tablets (Pfizer ...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 21 tablet | 295000 | |
| 63 tablet | 885000 |